Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pushen Capsules for ischemic stroke
ChiCTR2100052920Phase 4Not yet recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Oct 2021
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Pushen in ischemic stroke (2 arms), sponsored by Nanjing Drum-Tower Hospital. Primary endpoint: mRS score improvement rate at week 24. Planned start Oct 2021; status: not yet recruiting.
02
Drugs
Pushen
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2100052920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052920.